Skip to content
OpenCapital
Get started

Silexion Therapeutics SLXN Q4 2024 Annual earnings

Reported March 18, 2025 · Before market open

EPS-$20.76Miss by $19.78
EPS estimate-$0.98

Next report

Aug 11, 2026 (In 1 week)
EPS estimate-$21.20

Versus estimates

Diluted EPS

Q1 2026-$0.85Beat by $0.44Q4 2025-$2.39Miss by $1.21Q3 2025-$2.88Beat by $0.52Q2 2025-$4.32Miss by $1.17Q1 2025-$3.90Miss by $3.68
Q4 2024-$20.76Miss by $19.78

Ask the moment Silexion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Silexion Therapeutics report Q4 2024 earnings?
Silexion Therapeutics (SLXN) reported Q4 2024 earnings on March 18, 2025 before market open.
What were Silexion Therapeutics's Q4 2024 revenue and EPS?
Silexion Therapeutics reported eps of $-20.76 for Q4 2024.
Did Silexion Therapeutics beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.98 by $19.78.
Where can I find Silexion Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001178913-25-000887) directly on SEC EDGAR. The filing index links above go to sec.gov.